A LRRK2 G2019S mutation carrier from Turkey shares the Japanese haplotype

Neurogenetics

Volumn 10, Issue 3, 2009, Pages 271-273

  Pirkevi, C ^a   Lesage, S ^b,c,d   Condroyer, C ^b,c,d   Tomiyama, H ^e   Hattori, N ^e   Ertan, S ^f   Brice, A ^b,c,d,g   Basak A N ^a  

^a BOGAZICI UNIVERSITY   (Turkey)

^b INSERM   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d IFR 070   (France)

^e JUNTENDO UNIVERSITY   (Japan)

^f ISTANBUL UNIVERSITY   (Turkey)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Genetics; Haplotype; LRRK2; Parkinson's disease

Indexed keywords

LEUCINE RICH REPEAT KINASE 2; MUTANT PROTEIN; LRRK2 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE;

AGED; ARTICLE; CASE REPORT; FOUNDER EFFECT; HAPLOTYPE; HETEROZYGOTE; HUMAN; JAPANESE; PARKINSON DISEASE; PRIORITY JOURNAL; TURKEY (REPUBLIC); ASIAN; FEMALE; GENETICS; JAPAN; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; POINT MUTATION; POPULATION GENETICS;

AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; DNA MUTATIONAL ANALYSIS; FEMALE; GENETICS, POPULATION; HAPLOTYPES; HETEROZYGOTE; HUMANS; JAPAN; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PARKINSON DISEASE; POINT MUTATION; PROTEIN-SERINE-THREONINE KINASES; TURKEY;

EID: 70249150754     PISSN: 13646745     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10048-009-0173-5     Document Type: Article

References (8)

1. DG Healy M Falchi S O'Sullivan, et al. 2008 Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study Lancet Neurol 7 583 590 18539534 10.1016/S1474-4422(08)70117- 0 1:CAS:528:DC%2BD1cXptVWju7o%3D
2. MM Hulihan L Ishihara-Paul J Kachergus, et al. 2008 LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study Lancet Neurol 7 591 594 18539535 10.1016/S1474-4422(08)70116-9 1:CAS:528:DC%2BD1cXptVWju7g%3D
3. CP Zabetian CM Hutter D Yearout, et al. 2006 LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago Am J Hum Genet 79 752 758 16960813 10.1086/508025 1:CAS:528:DC%2BD28XhtVChurvO (Pubitemid 44452754)
4. J Kachergus IF Mata M Hulihan, et al. 2005 Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations Am J Hum Genet 76 4 672 680 15726496 10.1086/429256 1:CAS:528:DC%2BD2MXisleisLY%3D (Pubitemid 40432174)
5. S Lesage A Dürr M Tazir, et al. 2006 LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs N Engl J Med 354 4 422 423 16436781 10.1056/NEJMc055540 1:CAS:528:DC%2BD28XnslWisg%3D%3D (Pubitemid 43145082)
6. CP Zabetian H Morino H Ujike, et al. 2006 Identification and haplotype analysis of LRRK2 G2019S in Japanese patients with Parkinson disease Neurology 67 697 699 16728648 10.1212/01.wnl.0000227732.37801.d4 1:CAS:528: DC%2BD28XnvVynsL8%3D (Pubitemid 44273625)
7. H Tomiyama Y Li M Funayama, et al. 2006 Clinicogenetic study of mutations in LRRK2 exon 41 in Parkinson's disease patients from 18 countries Mov Dis 21 8 1102 1108 10.1002/mds.20886 (Pubitemid 44336593)
8. S Lesage AL Leutenegger P Ibanez, et al. 2005 LRRK2 haplotype analyses in European and North African families with Parkinson disease: a common founder for the G2019S mutation dating from the 13th century Am J Hum Genet 77 330 332 16145815 10.1086/432422 1:CAS:528:DC%2BD2MXms12ju7k%3D (Pubitemid 41022715)